| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1007/S00432-014-1660-0 |
| P698 | PubMed publication ID | 24752338 |
| P2093 | author name string | Peng Zhao | |
| Yi Luo | |||
| Xin Jia | |||
| Junmin Wang | |||
| Yongsheng Li | |||
| Yajun Tian | |||
| Shengxiang Wang | |||
| Maosheng Dong | |||
| Da Cai | |||
| Zequan Zhou | |||
| P2860 | cites work | SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas | Q21562575 |
| Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab | Q27640593 | ||
| Lapatinib plus capecitabine for HER2-positive advanced breast cancer | Q27851403 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology | Q28271671 | ||
| The distinctive nature of HER2-positive breast cancers | Q28278028 | ||
| Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers | Q28679173 | ||
| Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 | ||
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas | Q30491937 | ||
| Sox2 is required for maintenance and differentiation of bronchiolar Clara, ciliated, and goblet cells | Q33518513 | ||
| Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung | Q33531781 | ||
| Breast cancer in the 21st century: neu opportunities and neu challenges | Q34194240 | ||
| Development of Herceptin resistance in breast cancer cells | Q34293506 | ||
| Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex | Q34314489 | ||
| Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | Q34634936 | ||
| Sox2 Activates Cell Proliferation and Differentiation in the Respiratory Epithelium | Q35132159 | ||
| Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis | Q37742318 | ||
| Molecular mechanisms of cisplatin resistance | Q37926477 | ||
| Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization | Q38477505 | ||
| Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin. | Q40032261 | ||
| Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. | Q40144433 | ||
| Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells | Q40321992 | ||
| Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. | Q40461355 | ||
| Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance | Q40718678 | ||
| Characteristics of cell lines established from human gastric carcinoma | Q41735874 | ||
| Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. | Q42823593 | ||
| Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth | Q44120544 | ||
| HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. | Q44450066 | ||
| Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming | Q47735041 | ||
| Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). | Q53985281 | ||
| Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models | Q79218019 | ||
| P433 | issue | 7 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 1117-1124 | |
| P577 | publication date | 2014-04-22 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | SOX2 oncogenes amplified and operate to activate AKT signaling in gastric cancer and predict immunotherapy responsiveness | |
| P478 | volume | 140 |
| Q90975867 | Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis |
| Q101403597 | CLC-3 and SOX2 regulate the cell cycle in DU145 cells |
| Q47317931 | Cancer Stem Cell Suppressing Activity of Chrysotoxine, a bibenzyl from Dendrobium pulchellum. |
| Q89427633 | Changing the natural history of metachronous gastric cancer after H. pylori eradication |
| Q38809827 | Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients |
| Q90046434 | Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer |
| Q92086451 | High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors |
| Q61443681 | Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma |
| Q55295718 | Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. |
| Q38352847 | Immunohistochemistry as a surrogate for molecular testing: a review. |
| Q59135024 | OCT4, SOX2, and NAN OG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2 + breast cancer patients |
| Q38239137 | SOX2 and cancer: current research and its implications in the clinic |
| Q53223422 | SOX2 expression in gastrointestinal cancers of Iranian patients. |
| Q43201485 | SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas |
| Q37376417 | SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells |
| Q36548775 | SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma |
| Q38718397 | Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1. |
| Q89279586 | TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells |
| Q38733504 | The dark side of SOX2: cancer - a comprehensive overview |
| Q36857674 | The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer |
| Q35113261 | Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.